Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
Background
Cited by
Items 401–500 of 532
Dichotomy effects of Akt signaling in breast cancer
Peng, Z., Weber, J. C., Han, Z., Shen, R. Z., Zhou, W., Scott, J. R., Chan, M. W., & Lin, H.-J. L. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-61 · Cited by 9
“EMT, as well as overexpression of HER2, activation of PI3K, and loss of PTEN have all been associated with acquisition of stem/progenitor cell properties [23,24,26,4143].”
BackgroundResultInfluentialEmerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse
Singh, R., & Sharma, B. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.91119 · Cited by 8
Xu, H., Mu, J., Xiao, J., Wu, X., Li, M., Liu, T., & Liu, X. (2016) · Europe PMC (PubMed Central) · Cited by 8
Curcumin: Structure, Biology and Clinical Applications
Shankar, S., & Srivastava, R. K. (2012) · Springer eBooks · doi:10.1007/978-94-007-2923-0_17 · Cited by 9
“Furthermore, PI3K/Akt pathway is important in regulating the mammary stem/progenitor cells by promoting “-catenin downstream events through phosphorylation of GSK3“ (Korkaya et al. 2009).”
BackgroundTavakolpour, V., Kharkeshi, M. S., Soleimanpour‐Lichaei, H. R., Gardaneh, M., & Kouhkan, F. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102211 · Cited by 7
Saliu, T. P., Seneviratne, N. N., Faizan, M., Rajagopalan, U., Perera, D. C., Adhikari, A., Senathilake, K. S., Galhena, P., Tennekoon, K. H., & Samarakoon, S. R. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00199-z · Cited by 8
“CSCs have been identified as a major course of tumor recurrence, metastasis, and chemo-resistance cells (Korkaya et al. 2009; Liu et al. 2005, Arnaud-Sampaio et al. 2020; Ojha et al. 2015; Zhang et al. 2020) in many different cancer types.”
Kwon, Y., Chun, S., Nan, H., Nam, K., Lee, C., & Kim, S. Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9827 · Cited by 8
Bezerra, A. C. M., Baptista, L., Couto, M. N. A., & Kanashiro, M. M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070931 · Cited by 6
Cancer Stem Cells: Formidable Allies of Cancer
Deshpande, N., & Rangarajan, A. (2015) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-015-0451-7 · Cited by 6
Isolation of Breast Cancer Stem Cells by Single-Cell Sorting
Van, P., Vu, B. T., Phan, N. L.-C., Thanh, T., Gia, T., Nguyen, G. D. T., Van, T., Xuan, D., Hoang, M., & Kim, N. P. (2012) · InTech eBooks · doi:10.5772/51506 · Cited by 6
“Strategies include targeting the self-renewal of BCSCs [30]; [31], indirectly targeting the microenvironment [29]; [50]; [31] and directly killing BCSCs by chemical agents that induce differentiation [25]; [19]; [42]; [43], immunotherapy [4]; [5]; [40] and oncolytic viruses [26]; [34].”
BackgroundGhosh, S., Roy, R., Mukherjee, N., Ghosh, S., Jash, M., Jana, A., & Ghosh, S. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00331 · Cited by 6
Momeny, M., Arsiola, T., & Westermarck, J. K. (2021) · Biochemical Journal · doi:10.1042/bcj20210254 · Cited by 6
Riaz, M., Setyono-Han, B., Timmermans, M. A. M., Trapman-Jansen, A., Vries, J. B., Hollestelle, A., Janssens, R. C., Look, M. P., Schutte, M. E. M., Foekens, J. A., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3142-0 · Cited by 7
Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer
Nandi, S., & Bagchi, M. C. (2022) · Journal of cancer research updates · doi:10.30683/1929-2279.2022.11.09 · Cited by 6
“proteins thereby regulating cell differentiation [54-55].”
HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC
Honkanen, T. J., Wilenius, E., Koivunen, P., & Koivunen, J. P. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4048 · Cited by 6
Insights into the targeted elimination of BRCA1‐defective cancer stem cells
Somasundaram, V., & Srinivas, P. (2010) · Medicinal Research Reviews · doi:10.1002/med.20229 · Cited by 5
Modulation of miRNAs by Natural Agents: Nature’s way of dealing with cancer
(2015) · RNA & DISEASE · doi:10.14800/rd.861 · Cited by 7
Jia, Z. (2012) · Journal of Data Mining in Genomics & Proteomics · doi:10.4172/2153-0602.1000e102 · Cited by 5
EID1 plays a crucial role in proliferation of neural stem cell
Fu, X., Ding, B., Wang, C., Chen, C., Wang, J., Fei, X., & Xu, R. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.138 · Cited by 6
Stem cell and cancer stem cell games on the ECM field
Kamble, S. C., & Bapat, S. A. (2013) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2013.1e1002 · Cited by 5
“Thus factors including Wnt, Notch and Hedgehog ligands, insulin-like growth factor (IGF), platelet-derived growth factor (PDGF) and Matrix metalloproteinases (MMPs) are produced and are involved in the PI3K, NF-kB, Wnt, Hedgehog, Notch and Jak/STAT pathways to regulate tumor growth, progression and metastasis [31, 33–…”
BackgroundLoss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine
Borgato, G. B., Borges, G. Á., de Souza, A. P., SQUARIZE, C. H., & CASTILHO, R. M. (2020) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2020.05.001 · Cited by 5
Taweecheep, P., Khine, H. E. E., Hlosrichok, A., Ecoy, G. A. U., Sritularak, B., Prompetchara, E., Pithi Chanvorachote, B., & Chaotham, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5516655 · Cited by 5
“In vivo evidence suggests that Akt-driven CSC enrichment is mediated by activation of the Wnt/β-catenin pathway through GSK3β phosphorylation [56].”
BackgroundCCN2/CTGF silencing blocks cell aggregation in embryonal carcinoma P19 cell
Aguiar, D. P., Coelho‐Aguiar, J. M., & Abreu, J. G. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500019 · Cited by 5
Anti-Proliferative Effects of Selenium in HT-29 Colon Cancer Cells via Inhibition of Akt
Park, S.-Y., Kim, I.-S., Lee, S., Lee, S.-H., Jung, D.-W., Park, O.-J., & Kim, Y. (2012) · Journal of Life Science · doi:10.5352/jls.2012.22.1.55 · Cited by 4
“뿐만 아니라 Wnt 신호경로의 주요 조절자인 GSK3β의 인산화 를 촉진시킴으로써 Wnt 신호경로의 전사인자인 β-catenin의 핵 내 이동을 촉진하는 것으로 보고되었다[10].”
Tobin, G., Kalupahana, R. S., & Kulk, M. (2013) · InTech eBooks · doi:10.5772/55794 · Cited by 4
“Nonetheless, most of the therapeutic approaches available, inclusive of chemotherapy and radiation, lack the ability to effectively kill these populations [59-62].”
BackgroundAkt modes of stem cell regulation: more then meets the eye?
Calautti, E. (2013) · Discoveries · doi:10.15190/d.2013.8 · Cited by 4
Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy
Fares, J., Kanojia, D., Cordero, Á., Ulasov, I. V., & Lesniak, M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00014-2 · Cited by 6
Lee, C., & Chen, C. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1021688 · Cited by 4
RetractedRecent Developments in Targeting Breast Cancer Stem Cells
Sanchez, Y., & Martín, Á. G. (2011) · Recent Patents on Regenerative Medicine · doi:10.2174/2210296511101010001 · Cited by 3
“Activation of the PI3K/Akt pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo [53] as measured by aldefluor positive cell population, previously demonstrated to be enriched in mammary stem/progrenitor cells [17], and mammosphere formation.”
BackgroundUBE2T mediates the stemness properties of breast cancer cells through the mTOR signaling pathway
YIN, J., WANG, Y., Wei, G., & Wen, M. (2024) · Biocell · doi:10.32604/biocell.2024.049349 · Cited by 3
“Based on the expression levels of UBE2T in BCa tissues and cells and the association of BCSCs with cancer growth, metastasis, and relapse [27,28], we aimed to verify the exact role of UBE2T in BCSCs.”
BackgroundLi, L., Huang, J., Huang, T., Yao, J., Zhang, Y., Chen, M., Shentu, H., & Lou, H. (2023) · International Journal of Endocrinology · doi:10.1155/2023/5892731 · Cited by 4
Melnik, B. C., Weiskirchen, R., Weiskirchen, S., Stremmel, W., John, S. M., Leitzmann, C., & Schmitz, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1652297 · Cited by 4
“Akt-mediated phosphorylation of GSK3-β has been shown to enhance stem/progenitor cell enrichment by activating the Wnt/ β -catenin pathway (184).”
Üstün, F. (2019) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2019.0005 · Cited by 3
Castañeda, M., den Hollander, P., Werden, S. J., Ramirez‐Peña, E., Vasaikar, S. V., Kuburich, N. A., Gould, C., Soundararajan, R., & Mani, S. A. (2025) · Cancers · doi:10.3390/cancers17071114 · Cited by 3
“The link between FOXC2 and β -catenin has been previously shown by analysis of osteoblast differentiation, and β -catenin and FOXC2 have been individually linked to stemness trait acquisition in various cancers, including breast cancer [22,29,65].”
Breast Cancer Stem Cells: From Theory to Therapy
Conley, S. J., & Wicha, M. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_35 · Cited by 4
Self-citationBreast Cancer Heterogeneity: Need to Review Current Treatment Strategies
Malik, F. A., Körkaya, H., Clouthier, S. G., & Wicha, M. S. (2012) · Current Breast Cancer Reports · doi:10.1007/s12609-012-0093-5 · Cited by 3
“The same CSCs drive tumor growth and metastasis and by virtue of their relative resistance to traditional therapies such as cytotoxic chemotherapy and radiation may contribute to tumor recurrence [69–73].”
BackgroundSelf-citationB4 androgen ablation: attacking the prostate cancer stem cell
Wicha, M. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67460 · Cited by 3
Self-citationBreast cancer stem cells: a moving target for cancer nanomedicine
Mollenhauer, J., Knoop, A. S., Bak, M., Lænkholm, A., Thomassen, M., Kruse, T. A., & Høilund‐Carlsen, P. F. (2012) · European Journal of Nanomedicine · doi:10.1515/ejnm-2012-0006 · Cited by 3
Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells
Xu, W., Debeb, B. G., Lacerd, L., & Woodward, W. A. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010790909362 · Cited by 2
“Activation of AKT, the upstream signaling of -catenin, was also shown to increase breast TIC self-renewal [24].”
BackgroundKovacic, P., & Somanathan, R. (2017) · Global Journal of Health Science · doi:10.5539/gjhs.v9n8p66 · Cited by 2
The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer
Forissier, V., Wicinski, J., Castagné, M., Pinna, G., Lin, S., Grandon, A., Bonnet, C., Macario, M., Castellano, R., Valdenaire, S., et al. (2025) · Theranostics · doi:10.7150/thno.101393 · Cited by 2
Self-citationSoloxolone Methyl Induces Apoptosis in Mammospheres
Ertürk, E., Akgün, O., Yıldız, Y., KALKAN, P., Salomatina, O. V., Salakhutdinov, N. F., Ulukaya, E., & Arı, F. (2022) · TURKISH JOURNAL OF BIOLOGY · doi:10.2139/ssrn.4180774 · Cited by 2
Oki, S., Kageyama, S., Machihara, K., & Namba, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00523 · Cited by 2
Mouse Models to Study Leptin in Breast Cancer Stem Cells
Thiagarajan, P. S., & Reizes, O. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_7 · Cited by 2
AKT1 and AKT2 promote malignant transformation in human brain glioma LN229 cells
Zou, J., Wang, K., Han, L., Zhang, A., Shi, Z., Pu, P., & Kang, C. (2011) · Clinical Oncology and Cancer Research · doi:10.1007/s11805-011-0573-9 · Cited by 2
Signaling Pathways Regulating Stem Cells
Guo, X., Chen, J., Li, Z., & Xi, R. (2015) · Translational medicine research · doi:10.1007/978-94-017-7273-0_6 · Cited by 2
Cancer Stem Cells and the Microenvironment
Körkaya, H., Davis, A., & Wicha, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00010-x · Cited by 2
Self-citationBreast Cancer Stem Cells: Responsible for Therapeutic Resistance and Relapse?
Körkaya, H., & Malik, F. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_21 · Cited by 3
Cancer Stem Cells: Biology and Potential Therapeutic Applications
Mangoni, M., Sottili, M., Loi, M., Gerini, C., Meattini, I., & Livi, L. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_8 · Cited by 2
Breast cancer stem cells: new therapeutic approaches
Ferrari, P., & Nicolini, A. (2012) · Breast Cancer Management · doi:10.2217/bmt.12.43 · Cited by 2
Farmakovskaya, M. D., Хромова, Н. В., Kopnin, B. P., & Kopnin, P. (2016) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2016-15-3-06-14 · Cited by 2
Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations
Arif, A., Hansen, M. F., Alander, C. B., Monson, D. K., Reimer, N. B., & Drissi, H. (2019) · Techniques in Orthopaedics · doi:10.1097/bto.0000000000000408 · Cited by 2
Cancer Stem Cells: Novel Target Using Dietary Components for Prevention and Treatment
Dhar, A., Fogt, L., Subramaniam, D., & Anant, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-2630-7_2 · Cited by 2
Zhang, M., & Rosen, J. M. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200005 · Cited by 2
Therapeutic strategies to eliminate breast cancer stem cells
Klopp, A. H., & Woodward, W. A. (2009) · Current Breast Cancer Reports · doi:10.1007/s12609-009-0031-3 · Cited by 2
The Role of MicroRNAs in Regulating Cancer Stem Cells
Tuna, M., & Christopher, I. L. (2011) · InTech eBooks · doi:10.5772/24822 · Cited by 1
“, 2007) (Korkaya et al., 2009) (Zhao et al.”
Stem Cell Characters in Primary and Metastatic Tumour Establishment
Tsekrekou, M., Mavroudis, D., Kafetzopoulos, D., & Vassou, D. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_25 · Cited by 1
Pathology of Inflammatory Breast Cancer
Pérez-Sánchez, V. M., Maldonado-Martínez, H. A., Juarez-Sánchez, P., & Meneses-García, A. (2012) · Springer eBooks · doi:10.1007/978-0-85729-991-8_3 · Cited by 1
Role of Cancer Stem Cells of Breast, Colon, and Melanoma Tumors in the Response to Antitumor Therapy
Marchal, J. A., García, M. Á., Boulaiz, H., Perán, M., Alvarez, P. J., Prados, J. C., Melguizo, C., & Aránega, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-2415-0_15 · Cited by 1
“Moreover, recent findings identified perifosine, an Akt inhibitor, as a putative therapeutic agent for breast CSCs in vivo, because it reduces serial mammosphere formation (Korkaya et al., 2009).”
BackgroundCellules souches du cancer du sein : prendre le cancer à la racine
Launay, S., Ginestier, C., Birnbaum, D., & Charafe‐Jauffret, E. (2012) · ONCOLOGIE · doi:10.1007/s10269-012-2198-x · Cited by 2
“Les mécanismes d’action de la voie HER2 dans le cadre des CSC ont été bien documentés dans un autre travail [19].”
BackgroundSelf-citationEroles, P., Fidalgo, J. A. P., & Lluch, A. M. (2014) · Springer eBooks · doi:10.1007/978-94-017-8754-3_5 · Cited by 1
“Furthermore a previous study in vitro showed that AKT inhibition lead to a decrease in the number of CSC [ 95 ].”
BackgroundBioactive Lipids in Stem Cell Differentiation
Bieberich, E., & Wang, G. (2011) · InTech eBooks · doi:10.5772/22756 · Cited by 3
“…and tensin homolog deleted on chromosome 10 (PTEN) is a lipid phosphatase that catalyzes the hydrolysis of PIP3 to PIP2, which leads to inactivation of the Akt/PKB cell signaling pathway and loss of pluripotency in stem cells (Groszer et al., 2001; Korkaya et al., 2009; Otaegi et al., 2006).”
BackgroundAdvanced Models for Target Validation & Drug Discovery in Prostate Cancer
Åkerfelt, M., Härmä, V., & Nees, M. (2011) · InTech eBooks · doi:10.5772/25629 · Cited by 1
“The resulting tumor cells show a dramatically increased stem- or progenitor cell and self-renewing potential (Dubrovska et al., 2009; Korkaya et al., 2009; Mulholland et al., 2009).”
Potential Application of Natural Dietary Components to Target Cancer Stem Cells
Li, Y., Schwartz, S. J., & Sun, D. (2011) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/18522 · Cited by 1
“When ┚-catenin is phosphorylated at Ser33/Ser37/Thr41 by GSK3┚, it is immediately subject to ubiquitinproteasome degradation (Liu, C. et al. 2002; Takahashi-Yanaga and Sasaguri 2008).”
BackgroundInfluentialDavis, M. L., Gassner, K., Barrueco, R. R., & Llobet‐Navàs, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_12 · Cited by 1
Esmaeil, D. A. M., Ahmed, R. A., Mourad, M. I., & Gaballah, E. T. M. A. (2019) · Journal of Solid Tumors · doi:10.5430/jst.v9n1p13 · Cited by 1
Mushrooms: A Wealth of Resource for Prospective Stem Cell-Based Therapies
Shibu, M. A., Tamilselvi, S., Agrawal, D. C., & Huang, C. (2019) · Springer eBooks · doi:10.1007/978-981-13-6382-5_6 · Cited by 1
Preventing phenotypic plasticity in cancer to mitigate therapy resistance
Coatham, M. L., Jewer, M., & Postovit, L.-M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00002-4 · Cited by 1
Koul, B. (2019) · Springer eBooks · doi:10.1007/978-981-32-9147-8_1 · Cited by 1
Goltsev, А., Babenko, N. M., Gaevska, Y., Chelombytko, O. V., Bondarovich, N. A., Dubrava, T., Ostankov, M. V., Dimitrov, A. Y., Klochkov, V., Kavok, N. S., et al. (2015) · Genes and Cells · doi:10.23868/gc120489 · Cited by 4
Cancer Stem Cells and Head and Neck Squamous Cell Carcinomas
Lu, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_23 · Cited by 1
“Further analysis showed the AKT-driven stem/progenitor cell enrichment is mediated by the activation of the Wnt/ b -catenin pathway through phosphorylation of GSK-3 b [ 53 ] .”
BackgroundImpact of Dietary Interventions on Cancer Stem Cells
Gacche, R. N. (2021) · Springer eBooks · doi:10.1007/978-981-16-6050-4_9 · Cited by 1
Franco, S. D., Benfante, A., Iovino, F., Bonventre, S., Dieli, F., Stassi, G., & Todaro, M. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100021 · Cited by 1
Reply to Bonnefoix and Callanan: Significance of Akt/Wnt pathway in radiation resistance of TICs
Rosen, J. M., Zhang, M., & Hilsenbeck, S. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003863107 · Cited by 1
Cancer-Initiating Cells in Colorectal Cancer
Kreso, A., Gibson, L., & O'Brien, C. A. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_5 · Cited by 1
Is Glycogen Synthase Kinase-3β an Ultraconserved Kernel Enzyme?
Fenger, M., Haugaard, S. B., Andersen, O., Madsbad, S., Werge, T. M., & Linneberg, A. R. (2009) · Gene Expression to Genetical Genomics · doi:10.4137/gegg.s2912 · Cited by 2
Role of Cancer Stem Cell in Mammary Carcinogenesis and Its Clinical Implication
Liu, Y., & Liu, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-6262-6_17
“Elevated level of Hedgehog and Wnt signalling is found associated with mammospheres and differentiation is induced when the pathways are inhibited (Liu et al. 2006; Korkaya et al. 2009).”
BackgroundSoria, A., del Toro, J. M., Fuentes, R., & Cortés, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-8754-3_10
Meier‐Abt, F. (2013) · edoc (University of Basel) · doi:10.5451/unibas-006163851
“Moreover, the Wnt/β-catenin pathway is activated following knockdown of the tumor suppressor gene PTEN in human breast cells (Korkaya et al., 2009), and most invasive breast carcinomas exhibit downregulation of the secreted Wnt inhibitor Secreted Frizzled-Related Protein1 (Sfrp1) (Roarty and Rosen, 2010; Ugolini et al.”
BackgroundBreast Cancer Stem Cells – A Review
Julia, S., & Ritter, E. (2011) · InTech eBooks · doi:10.5772/25194
Leptin Signaling in the Regulation of Stem and Cancer Stem Cells
Guo, S., Singh, K. K., Lillard, J. W., & Yang, L. P. H. (2014) · Wiley eBooks · doi:10.1002/9781118356203.ch26
Human Mammary Epithelial Stem/Progenitor Cells
Keller, P. J., Arendt, L. M., & Kuperwasser, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_17
The role of cFLIP in breast cancer stem cells
French, R. (2014) · ORCA Online Research @Cardiff (Cardiff University)
DNA Repair Mechanisms in Breast Cancer Stem Cells
Yin, H., & Glass, J. (2012) · Springer eBooks · doi:10.1007/978-94-007-4590-2_6 · Cited by 1
Nanomedicines, a strategy to evade multidrug resistance
Pereira, C. C. D. F. A. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Targeting breast cancer stem cells: Principle and update
Pham, P. V. (2012) · Biomedical Reports
Cuello-Carrión, F. D., Fanelli, M. A., Castro, G. N., Cayado-Gutiérrez, N., & Ciocca, D. R. (2015) · Current Cancer Therapy Reviews · doi:10.2174/1573394712666151215213709
Regulation of Angiogenesis via Notch Signaling in Human Malignancy
Guo, S., Liu, M., Wang, G., & Yang, L. P. H. (2013) · CRC Press eBooks · doi:10.1201/b14842-3
Aptamer-mediated siRNA delivery to target colon cancer stem cells
Shamaileh, H. A. (2016) · Deakin Research Online (Deakin University)
Biological and therapeutic aspects of breast cancer progression
Karthik, G.-M. (2017) · Figshare
Schäfer, A. (2012) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
Baker, A. T. (2017) · Loyola eCommons (Loyola University of Chicago)
Breast Cancer Stem Cells: Tumourspheres and Implications for Therapy
Morrison, B. J. (2011) · Griffith Research Online · doi:10.25904/1912/1434
A Multi-Pronged Modulation of Signaling Pathways in Targeting Breast Cancer Stem Cells.
Lee, H.-F. (2012) · Deep Blue (University of Michigan)
Nutrition, (Cancer-)Stem Cells and Cancer Prevention
Mahn, F., Franck, S., Czauderna, C., & Marquardt, J. U. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016506-00294
Rehman, S., Haynes, J., Lima‐Fernandes, E., Puri, A., Haller, A., Leung, C., Agro, L. A., Wang, Y., & O'Brien, C. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00007-3 · Cited by 2
Characterization and Inhibition of Canine Osteosarcoma Tumor-Initiating Cells
Pfent, C. M. (2015) · OakTrust (Texas A&M University Libraries)
Empowering host immunity by kinase-targeting in LSC
Wang, Q. (2020) · Blood Science · doi:10.1097/bs9.0000000000000052
“The cooperative role of the Wnt–b-catenin and PI3K-Akt pathways in resistance to multiple anticancer therapies was reported.(6) The cooperative activation of these two pathways was enriched in LSCs (LinCD3c-Kit) while infrequently”
BackgroundGlioma stem cells and associated molecular mechanisms in Glioblastoma Chemoresistance
Solomou, G., & Watts, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00005-1
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.